These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 24209998

  • 1. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N, Barwick BG, Moreno CS, Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C, Kerstann KF, Sledge GW, Abramovitz M, Bouzyk M, De P, Leyland-Jones BR.
    BMC Cancer; 2013 Nov 10; 13():537. PubMed ID: 24209998
    [Abstract] [Full Text] [Related]

  • 2. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N.
    Oncotarget; 2016 Jul 12; 7(28):43124-43149. PubMed ID: 27281609
    [Abstract] [Full Text] [Related]

  • 3. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
    Henry C, Quadir A, Hawkins NJ, Jary E, Llamosas E, Kumar D, Daniels B, Ward RL, Ford CE.
    J Cancer Res Clin Oncol; 2015 Feb 12; 141(2):243-54. PubMed ID: 25209439
    [Abstract] [Full Text] [Related]

  • 4. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.
    Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.
    Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES.
    Oncotarget; 2014 May 15; 5(9):2736-49. PubMed ID: 24811362
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L, Li X, Li H, Chen H, Liu H.
    Tumour Biol; 2016 Oct 15; 37(10):13821-13829. PubMed ID: 27481517
    [Abstract] [Full Text] [Related]

  • 9. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, Li H.
    Oncol Rep; 2017 Feb 15; 37(2):895-902. PubMed ID: 27959422
    [Abstract] [Full Text] [Related]

  • 10. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW, Merkel AR, Page JM, Ruppender NS, Guelcher SA, Sterling JA.
    Clin Exp Metastasis; 2014 Dec 15; 31(8):945-59. PubMed ID: 25359619
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.
    Du Q, Zhang X, Liu Q, Zhang X, Bartels CE, Geller DA.
    Cancer Res; 2013 Nov 01; 73(21):6526-37. PubMed ID: 24008318
    [Abstract] [Full Text] [Related]

  • 12. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y, Jin K, van Pelt GW, van Dam H, Yu X, Mesker WE, Ten Dijke P, Zhou F, Zhang L.
    Cancer Res; 2016 Jun 01; 76(11):3364-75. PubMed ID: 27197202
    [Abstract] [Full Text] [Related]

  • 13. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
    Jiang Y, Sheng H, Meng L, Yue H, Li B, Zhang A, Dong Y, Liu Y.
    World J Surg Oncol; 2017 Jan 06; 15(1):9. PubMed ID: 28061901
    [Abstract] [Full Text] [Related]

  • 14. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.
    Bilir B, Kucuk O, Moreno CS.
    J Transl Med; 2013 Nov 04; 11():280. PubMed ID: 24188694
    [Abstract] [Full Text] [Related]

  • 15. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
    Tzeng HE, Yang L, Chen K, Wang Y, Liu YR, Pan SL, Gaur S, Hu S, Yen Y.
    Oncotarget; 2015 May 10; 6(13):11061-73. PubMed ID: 25857298
    [Abstract] [Full Text] [Related]

  • 16. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.
    Meier-Abt F, Milani E, Roloff T, Brinkhaus H, Duss S, Meyer DS, Klebba I, Balwierz PJ, van Nimwegen E, Bentires-Alj M.
    Breast Cancer Res; 2013 Apr 29; 15(2):R36. PubMed ID: 23621987
    [Abstract] [Full Text] [Related]

  • 17. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B.
    Oncotarget; 2016 Feb 02; 7(5):5754-68. PubMed ID: 26735577
    [Abstract] [Full Text] [Related]

  • 18. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    Fatima I, El-Ayachi I, Taotao L, Lillo MA, Krutilina RI, Seagroves TN, Radaszkiewicz TW, Hutnan M, Bryja V, Krum SA, Rivas F, Miranda-Carboni GA.
    PLoS One; 2017 Feb 02; 12(12):e0189864. PubMed ID: 29281678
    [Abstract] [Full Text] [Related]

  • 19. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
    Wu L, Zhao JC, Kim J, Jin HJ, Wang CY, Yu J.
    Cancer Res; 2013 Oct 01; 73(19):6068-79. PubMed ID: 23913826
    [Abstract] [Full Text] [Related]

  • 20. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
    Shen H, Yan W, Yuan J, Wang Z, Wang C.
    J Exp Clin Cancer Res; 2019 Jun 07; 38(1):243. PubMed ID: 31174562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.